Arrowhead Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA interference therapies for the treatment of diseases. They focus on liver diseases, including hepatitis B and alpha-1 antitrypsin deficiency. Their innovative approach to gene silencing has the potential to revolutionize the field of medicine.
Notification